Jens Grosse

547 total citations
19 papers, 443 citations indexed

About

Jens Grosse is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jens Grosse has authored 19 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Jens Grosse's work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Jens Grosse is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Jens Grosse collaborates with scholars based in Germany, Kazakhstan and United States. Jens Grosse's co-authors include Arnold Ganser, Jens Atzpodien, Anke Franzke, Iris Dallmann, Jan Buer, Sya N. Ukena, Uta Kunter, Matthias Volkenandt, Anette Duensing and Udo Baron and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

Jens Grosse

19 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens Grosse Germany 11 255 218 139 85 56 19 443
F W Jacobsen Norway 8 247 1.0× 113 0.5× 207 1.5× 208 2.4× 26 0.5× 9 547
Ilaria Cattarossi Italy 11 336 1.3× 154 0.7× 309 2.2× 64 0.8× 16 0.3× 14 569
Yu Okajima Japan 10 175 0.7× 108 0.5× 143 1.0× 64 0.8× 26 0.5× 12 338
Nisha Shah United States 13 207 0.8× 143 0.7× 230 1.7× 174 2.0× 24 0.4× 18 503
Naoyuki Anzai Japan 13 226 0.9× 131 0.6× 216 1.6× 128 1.5× 33 0.6× 24 487
Sabina Pierpaoli Italy 12 166 0.7× 76 0.3× 230 1.7× 188 2.2× 40 0.7× 14 505
Alexander C. Lewis Australia 8 130 0.5× 91 0.4× 204 1.5× 63 0.7× 61 1.1× 11 371
Takako Tsujimoto Japan 9 248 1.0× 159 0.7× 160 1.2× 203 2.4× 19 0.3× 9 513
Caroline E. Zuber France 8 417 1.6× 187 0.9× 124 0.9× 80 0.9× 11 0.2× 8 624
Saul J. Sharkis United States 6 183 0.7× 178 0.8× 283 2.0× 384 4.5× 62 1.1× 6 703

Countries citing papers authored by Jens Grosse

Since Specialization
Citations

This map shows the geographic impact of Jens Grosse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Grosse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Grosse more than expected).

Fields of papers citing papers by Jens Grosse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Grosse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Grosse. The network helps show where Jens Grosse may publish in the future.

Co-authorship network of co-authors of Jens Grosse

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Grosse. A scholar is included among the top collaborators of Jens Grosse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Grosse. Jens Grosse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ukena, Sya N., Sarvari Velaga, Philipp Ivanyi, et al.. (2011). Isolation strategies of regulatory T cells for clinical trials: Phenotype, function, stability, and expansion capacity. Experimental Hematology. 39(12). 1152–1160. 43 indexed citations
2.
Ukena, Sya N., Sarvari Velaga, Robert Geffers, et al.. (2011). Human regulatory T cells in allogeneic stem cell transplantation. Blood. 118(13). e82–e92. 53 indexed citations
3.
Ukena, Sya N., Jens Grosse, Eva M. Weissinger, et al.. (2010). Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4+CD25highCD127low/− regulatory T cells. Annals of Hematology. 90(2). 213–218. 38 indexed citations
4.
Franzke, Anke, Robert Geffers, Wenji Piao, et al.. (2006). Identification of novel regulators in T-cell differentiation of aplastic anemia patients. BMC Genomics. 7(1). 263–263. 14 indexed citations
5.
Rosenstiel, Philip, Klaus Huse, C. Sina, et al.. (2006). Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun. 9 indexed citations
6.
Piao, Wenji, Jens Grosse, Andreas Czwalinna, et al.. (2005). Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemia. Experimental Hematology. 33(7). 804–810. 3 indexed citations
8.
Schrader, Andres Jan, Michael Probst‐Kepper, Jens Grosse, et al.. (2001). Tumour microdissemination and survival in metastatic melanoma.. PubMed. 20(5B). 3619–24. 6 indexed citations
9.
Schrader, Andres Jan, Jens Grosse, Uta Kunter, et al.. (2000). Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells. Melanoma Research. 10(4). 355–362. 22 indexed citations
10.
Meyer, Nadia, Anette Duensing, Gerasimos Anastassiou, et al.. (1999). Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastine.. PubMed. 19(2C). 1509–12. 10 indexed citations
11.
Duensing, Stefan, et al.. (1998). Loss of VLA-3 (CD49c/CD29) Expression in Two Multidrug Resistant Burkitt's Lymphoma Cell Lines. Cancer Biotherapy and Radiopharmaceuticals. 13(5). 369–373. 1 indexed citations
12.
Duensing, Anette, et al.. (1998). Elevated Plasma Levels of Interleukin-1 Receptor Antagonist are Associated with Decreased Cellular BCL-2 Oncoprotein Expression in B-Chronic Lymphocytic Leukemia. Cancer Biotherapy and Radiopharmaceuticals. 13(5). 383–385. 1 indexed citations
13.
Probst‐Kepper, Michael, Andres Jan Schrader, Jan Buer, et al.. (1997). Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma. British Journal of Haematology. 98(2). 488–491. 7 indexed citations
14.
Anastassiou, Gerasimos, Stefan Duensing, Gustav Steinhoff, et al.. (1996). Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1): A Potential Prognostic Marker Involved in Leukocyte Infiltration of Renal Cell Carcinoma. Oncology. 53(2). 127–132. 21 indexed citations
15.
Kunter, Uta, Jan Buer, M. Probst, et al.. (1996). Peripheral Blood Tyrosinase Messenger RNA Detection and Survival in Malignant Melanoma. JNCI Journal of the National Cancer Institute. 88(9). 590–594. 125 indexed citations
16.
Duensing, Anette, Nicholas J. Meyer, Gerasimos Anastassiou, et al.. (1996). Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line.. PubMed. 16(2). 65–72. 10 indexed citations
17.
Hänninen, Enrique Lopez, Thomas Menzel, A. Schomburg, et al.. (1994). In Vivo Time and Dose Dependency of Interleukin-6 Secretion in Response to Low-Dose Subcutaneous Recombinant Interleukin-2. PubMed. 9(4). 307–316. 9 indexed citations
18.
Dallmann, Iris, Jens Grosse, Jan Buer, et al.. (1994). Immunocytochemical Detection of P-Glycoprotein: Initial Expression Correlates with Survival in Renal Cell Carcinoma Patients. Oncology. 51(4). 309–313. 20 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026